What is a stock summary page? Click here for an overview.
Business Description
aap Implantate AG
ISIN : DE000A3H2101
Description
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.36 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | -1.36 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -0.43 | |||||
| Beneish M-Score | -3.16 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -19.8 | |||||
| 3-Year EBITDA Growth Rate | 35.6 | |||||
| 3-Year EPS without NRI Growth Rate | 37.6 | |||||
| 3-Year FCF Growth Rate | 29.6 | |||||
| 3-Year Book Growth Rate | -25.8 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 13.72 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.85 | |||||
| 9-Day RSI | 34.33 | |||||
| 14-Day RSI | 37.58 | |||||
| 3-1 Month Momentum % | -4.02 | |||||
| 6-1 Month Momentum % | -29.24 | |||||
| 12-1 Month Momentum % | 112.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.12 | |||||
| Quick Ratio | 1.03 | |||||
| Cash Ratio | 0.28 | |||||
| Days Inventory | 923.89 | |||||
| Days Sales Outstanding | 70.22 | |||||
| Days Payable | 331.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -37.1 | |||||
| Shareholder Yield % | -10.04 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 81.45 | |||||
| Operating Margin % | -34.06 | |||||
| Net Margin % | -33.34 | |||||
| FCF Margin % | -22.81 | |||||
| ROE % | -32.25 | |||||
| ROA % | -20.14 | |||||
| ROIC % | -25.17 | |||||
| 3-Year ROIIC % | -445.96 | |||||
| ROC (Joel Greenblatt) % | -37.7 | |||||
| ROCE % | -26.06 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.08 | |||||
| PB Ratio | 1.28 | |||||
| Price-to-Tangible-Book | 1.57 | |||||
| EV-to-EBIT | -6.11 | |||||
| EV-to-EBITDA | -9.94 | |||||
| EV-to-Revenue | 2.02 | |||||
| EV-to-FCF | -8.6 | |||||
| Price-to-GF-Value | 1.34 | |||||
| Price-to-Median-PS-Value | 0.41 | |||||
| Price-to-Net-Current-Asset-Value | 7.84 | |||||
| Earnings Yield (Greenblatt) % | -16.36 | |||||
| FCF Yield % | -13.3 | |||||
| Forward Rate of Return (Yacktman) % | -8.22 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
aap Implantate AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 12.06 | ||
| EPS (TTM) (€) | -0.49 | ||
| Beta | 1.05 | ||
| 3-Year Sharpe Ratio | -0.03 | ||
| 3-Year Sortino Ratio | -0.06 | ||
| Volatility % | 99.25 | ||
| 14-Day RSI | 37.58 | ||
| 14-Day ATR (€) | 0.06227 | ||
| 20-Day SMA (€) | 1.6635 | ||
| 12-1 Month Momentum % | 112.74 | ||
| 52-Week Range (€) | 0.73 - 2.98 | ||
| Shares Outstanding (Mil) | 13.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
aap Implantate AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
aap Implantate AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
aap Implantate AG Frequently Asked Questions
What is aap Implantate AG(XTER:AAQ1)'s stock price today?
The current price of XTER:AAQ1 is €1.49. The 52 week high of XTER:AAQ1 is €2.98 and 52 week low is €0.73.
When is next earnings date of aap Implantate AG(XTER:AAQ1)?
The next earnings date of aap Implantate AG(XTER:AAQ1) is .
Does aap Implantate AG(XTER:AAQ1) pay dividends? If so, how much?
aap Implantate AG(XTER:AAQ1) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers